By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN
During J.P. Morgan Healthcare Week, presenting your technology in front of active capital allocators is one of the most effective ways to accelerate an early-stage fundraising campaign. For Seed, Series A, and Series B founders, a well-executed pitch can compress months of outreach into four days of high-velocity investor dialogue.
However, the reality on the ground in San Francisco is that the quality of pitch events varies widely.
The Reality of JPM Pitch Events: Why Quality Matters
Every January, dozens of satellite pitch sessions, demo days, and presentation showcases compete for attention across downtown San Francisco. Unfortunately, many of these formats end up creating little tangible value for founders:
- The “Empty Room” Syndrome: Startups are placed into peripheral side-rooms where the audience consists mostly of fellow founders waiting for their turn, rather than genuine capital allocators with active checkbooks.
- One-Way Broadcasts: Conventional pitch sessions offer five to ten minutes of uninterrupted presentation time, after which founders simply walk off the stage. There is no dialogue, no live questioning, and no way to know whether the narrative resonated.
- The Follow-Up Void: Once a session ends, founders are left guessing which investors in the room were genuinely interested, leading to cold post-event follow-ups that rarely convert.
For early-stage innovators who are investing significant capital and time to be in San Francisco, pitching cannot be a vanity exercise. It must deliver qualified access, real-time feedback, and direct partnering continuity.
Why the RESI Innovator’s Pitch Challenge (IPC) Provides a Superior Model
The Innovator’s Pitch Challenge (IPC) at RESI JPM 2027 was engineered specifically to solve the shortcomings of typical conference showcases. Held during the in-person days at the San Francisco Marriott Marquis (January 11 and 12), the IPC integrates presentation visibility with structured due diligence:
| IPC Package Feature |
What Is Included |
Strategic Value for Founders |
| Two (2) Full Hybrid Passes |
Includes two standard passes covering 2 in-person days (Jan 11-12) and 3 virtual partnering days (Jan 13, 18, 19). |
$6,590 standard value: Full access to the 1-on-1 partnering platform, investor panels, and educational workshops. |
| Live Pitch & Real Q&A |
Present on stage to a dedicated panel of active healthcare investor judges, followed by interactive live Q&A. |
Eliminates one-way broadcasting and connects directly with active capital allocators deploying funds into your sector. |
| Investor Evaluation Sheet |
Receive a consolidated report compiled directly from judge scorecards and anonymous qualitative notes. |
Actionable intelligence on how institutional investors evaluate your science, team, and commercial roadmap. |
| Dedicated Exhibit & Poster* |
Reserved poster board space in the high-traffic Yerba Buena exhibition hall with free printing for one (1) poster*. |
A dedicated physical base camp for two full days to anchor spontaneous walk-up meetings and follow-up discussions. |
*Note on Poster Printing: Free printing is provided for one (1) poster per participating company, provided that print-ready artwork is submitted prior to the designated printing deadline.
By combining live stage presentation with the official Investor Evaluation Sheet, IPC finalists receive invaluable data on how their scientific milestones, regulatory pathways, and commercial models are perceived by active decision-makers.
Execution: How to Pitch to Investors and Handle Live Q&A
Being selected for an investor pitch session is only the first step. The real differentiator between a polite response and a request for a follow-up meeting is how effectively you execute on stage.
When presenting to institutional healthcare investors, founders must navigate two fundamental challenges:
- Translating Science into Commercial Milestones: Investors evaluate hundreds of assets during JPM Week. Your pitch must quickly articulate not just how your technology works, but how your next milestone materially de-risks the asset and creates a value inflection point.
- Mastering the Q&A Defense: The question-and-answer period is where investors test the depth of your leadership team. Whether responding to inquiries regarding regulatory flexibility, clinical trial design, competitive moats, or valuation expectations, your answers need to be direct, transparent, and grounded in data.
To assist founders in refining their presentations, structuring compelling pitch narratives, and preparing for live investor inquiries, our team conducted a dedicated strategy session. You can review the complete discussion as you finalize your materials:
[Webinar Recording] Pitching Strategy & Q&A Educational Session
Pitch slots across therapeutics, medical devices, diagnostics, and digital health tracks are strictly capped to ensure high judge-to-presenter ratios and dedicated evaluation time. The application deadline for the RESI JPM 2027 Innovator’s Pitch Challenge is Wednesday, November 11, 2026. Applications are reviewed and confirmed on a rolling basis, and sessions regularly fill before the final deadline.
If you are raising capital and want to position your company directly in front of active buy-side investors during JPM Healthcare Week, secure your application today:
